WW domain-binding protein 2 overexpression prevents diet-induced liver steatosis and insulin resistance through AMPKβ1

Nonalcoholic fatty liver disease (NAFLD) is prevalent clinically and can lead to more serious chronic liver disease. However, the pathological mechanism is still unclear, and thus, there are no approved drugs on the market. Transcriptional coactivator WW domain-binding protein 2 (WBP2) is a newly di...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Zhe, Li, Yue, Fan, Siyuan, An, Jie, Luo, Xi, Liang, Minglu, Zhu, Feng, Huang, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930037/
https://www.ncbi.nlm.nih.gov/pubmed/33658485
http://dx.doi.org/10.1038/s41419-021-03536-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930037/
https://www.ncbi.nlm.nih.gov/pubmed/33658485
http://dx.doi.org/10.1038/s41419-021-03536-8

Ejemplares similares